Next Article in Journal
Self-Assembled Cannabigerol-Based Nanoparticles: Design, Synthesis, and Antiproliferative Activity
Previous Article in Journal
Preparation of Carrier-Free Inhalable Dry Powder of Rivaroxaban Using Two-Step Milling for Lung-Targeted Delivery
Previous Article in Special Issue
Novel Lipid Formulation Increases Absorption of Oral Cannabidiol (CBD)
 
 
Article

Article Versions Notes

Pharmaceutics 2025, 17(5), 635; https://doi.org/10.3390/pharmaceutics17050635
Action Date Notes Link
article pdf uploaded. 10 May 2025 12:11 CEST Version of Record https://www.mdpi.com/1999-4923/17/5/635/pdf-vor
article supplementary file uploaded. 10 May 2025 12:11 CEST - https://www.mdpi.com/1999-4923/17/5/635#supplementary
article pdf uploaded. 12 May 2025 06:50 CEST Updated version of record https://www.mdpi.com/1999-4923/17/5/635/pdf-vor
article xml file uploaded 13 May 2025 12:03 CEST Original file -
article xml uploaded. 13 May 2025 12:03 CEST Update https://www.mdpi.com/1999-4923/17/5/635/xml
article pdf uploaded. 13 May 2025 12:03 CEST Updated version of record https://www.mdpi.com/1999-4923/17/5/635/pdf
article html file updated 13 May 2025 12:07 CEST Original file https://www.mdpi.com/1999-4923/17/5/635/html
Back to TopTop